Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
第一作者:
Omnia M,Ali
第一单位:
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Arab Academy for Science, Technology and Maritime Transport, El-Alamein 1029, Egypt.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);鞣花酸(Ellagic Acid);人类(Humans);乳铁蛋白(Lactoferrin);分子结构(Molecular Structure);纳米粒子(Nanoparticles);粒子大小(Particle Size);多孔性(Porosity);二氧化硅(Silicon Dioxide);构效关系(Structure-Activity Relationship);表面特性(Surface Properties);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1016/j.colsurfb.2020.110824
PMID
32023511
发布时间
2020-11-23
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文